For those of us with MM in whatever stage, your number one website for up-to-date info and resources is International Myeloma Foundation.
My chapter in Mpls recently sent out info on a webinar that they held, and I will include a link to the slide show deck for you to view, but I am told it is also on the website.
In today’s COVID-19 climate, we all need to be extra careful and follow the guidelines of HEALTH PROFESSIONALS and not politicians. Do what is best for you and your family based on your diagnosis, that is the number one priority.
Stay safe out there, we all are relying on you to do so!
It has been a very long time since I last posted, but now is a great time to share some info for those of us on the MM journey and how to protect ourselves and stay up on the COVID-19 threat.
Please follow the link and stay safe out there everyone.
The coronavirus is on the minds of global citizens and all myeloma patients. Dr. Joshua Richter shares an incredible amount of information for myeloma patients to navigate their care in these uncertain times. He shares drugs patients may want to ask their doctors about, considerations for stem cell transplant, the status of some myeloma clinical trials, tradeoffs of using IVIG, and potential therapies being used to treat the coronavirus. This is a must-read show to learn how the coronavirus is affecting myeloma patients and how they can be prepared.
READ IT ALL HERE >>
The expansion part of a Phase 1/2 clinical trial testing tinostamustine in relapsed or refractory blood cancers has begun treating the first patient.
READ THE ARTICLE HERE
Venclexta trial deaths force AbbVie, Roche to stop recruiting myeloma patients
Deaths Halt Drug Trials – READ MORE
Johnson & Johnson’s Darzalex is already on track to nab a second multiple myeloma nod in newly diagnosed patients in the U.S., but its journey with England’s cost watchdog hasn’t been so smooth.
Read it all here…